nedaplatin has been researched along with Mucositis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furutani, K; Goto, Y; Hanai, N; Hasegawa, Y; Hirakawa, H; Ito, J; Kodaira, T; Ozawa, T; Suzuki, H; Tachibana, H; Tomita, N | 1 |
| Kakehata, S; Kimura, H; Kobayashi, W; Nagahata, M; Sakaki, H; Sato, H; Teh, BG | 1 |
2 other study(ies) available for nedaplatin and Mucositis
| Article | Year |
|---|---|
Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mucositis; Neoplasm Recurrence, Local; Organoplatinum Compounds; Postoperative Period; Radiotherapy, Adjuvant; Survival Analysis | 2013 |
Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Mucositis; Organoplatinum Compounds; Prognosis; Quality of Life; Survival Rate; Taxoids; Treatment Outcome | 2010 |